|
|
|
Volumn 25, Issue 5, 1998, Pages 525-537
|
|
Strategies for reduction of anthracycline cardiac toxicity
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
ANTHRACYCLINE DERIVATIVE;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
IDARUBICIN;
LIPOSOME;
METHOTREXATE;
MITOXANTRONE;
PACLITAXEL;
RAZOXANE;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CHILDHOOD CANCER;
CLINICAL TRIAL;
DIAGNOSTIC TEST;
DRUG EFFICACY;
DRUG FORMULATION;
HEART SCINTISCANNING;
HUMAN;
IMMUNOSCINTIGRAPHY;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
PATHOLOGY;
PRIORITY JOURNAL;
REVIEW;
ADULT;
ANIMALS;
ANTHRACYCLINES;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARDIOMYOPATHIES;
CARDIOVASCULAR AGENTS;
CHELATING AGENTS;
CHILD;
CLINICAL TRIALS;
DIAGNOSTIC IMAGING;
HUMANS;
LIPOSOMES;
RAZOXANE;
|
|
EID: 0031722185
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (58)
|
|
References (94)
|
